U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 151 - 160 of 940

Community Safety Topic - Opioids

This overview of opioids from the NSC includes information on opioid misuse, recognizing signs of an overdose, prescription painkillers and chronic pain, and more.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Policymakers and Payers
First Responders
Source
National Safety Council (NSC)
Year
Resource Type
Web Page

Comparison of Health Centers and Certified Community Behavioral Health Clinics

This chart compares similarities and differences between Federally Qualified Health Centers (FQHCs) and Certified Community Behavioral Health Clinics.
Format
Fact Sheet/Brochure
Audience
Policymakers and Payers
Behavioral Health Providers
Other Team Members
Communities
Source
National Association of Community Health Centers (NACHC)
Year
Resource Type
PDF
File Size
218 KB

Connecting Communities to Substance Use Services: Practical Tools for First Responders

This guide provides practical, evidence-based information that first responder agencies, their partners, and communities can use to implement or expand practices and programs for linking people to substance use services.
Format
Report/Paper/Issue Brief
Audience
First Responders
Communities
Source
Substance Abuse and Mental Health Services Administration (SAMSHA)
Year
Resource Type
PDF
File Size
16.6 MB

Considerations for Buprenorphine Initiation and Maintenance Care

This virtual public meeting which explored real-world experiences and scientific evidence for buprenorphine initiation strategies, as well as medication dosing and management during continued treatment across different care settings
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Regan-Udall Foundation for the FDA
Year
Resource Type
Video

DAWN 2022 Non-Fatal Overdoses Short Report

This report from the Drug Abuse Warning Network (DAWN) focuses on estimates and characteristics of non-fatal overdoses for emergency department visits from January, 2021–June, 2022.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Policymakers and Payers
Communities
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
65.1 KB

DAWN Findings from Drug-Related Emergency Department Visits, 2022

This report provides national estimates from the Drug Abuse Warning Network (DAWN) for 2022 data on drug-related emergency department visits, to inform programs to aid in preventing overdose and substance use-related health consequences.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Policymakers and Payers
Communities
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
PDF
File Size
775 KB

DEA Announces Important Change to Registration Requirement

This letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Drug Enforcement Administration (DEA)
Year
Resource Type
PDF
File Size
148 KB

Digital Therapeutics (DTx) Product Library

To help key stakeholders understand and differentiate digital therapeutics from the thousands of other mobile health apps that are available, this library highlights evidence-based innovative digital therapeutics products.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Policymakers and Payers
Source
Digital Therapeutics Alliance (DTA)
Year
Resource Type
Web Page